iCAD, Inc. - ROE
ICAD
Price:
$3.87
Market Cap:
$106.31M
iCAD, Inc. specializes in delivering advanced solutions for cancer management, encompassing sophisticated image analysis tools, streamlined workflow optimization, and targeted radiation therapy. While primarily operating in the United States, the company also maintains a significant international presence. Its operations are organized into two principal divisions: Cancer Detection and Cancer Therapy. In the Cancer Detection segment, iCAD provides a range of innovative technologies. This includes the PowerLook platform, which serves as a central host for artificial intelligence algorithms and facilitates seamless communication between imaging acquisition devices, storage systems, and review p...[Read more]
Industry
Medical - Devices
IPO Date
1984-12-13
Stock Exchange
NASDAQ
Ticker
ICAD
PE Ratio
[-20.37]
ROE
[-5.67%]
Current Ratio
[3.66]
Dividend Yield
[0%]
Enterprise Value
[86.59M]
Dividend History
The ROE as of June 2026 (TTM) for iCAD, Inc. (ICAD) is -5.67%
According to iCAD, Inc.’s latest financial reports and current stock price. The company's current ROE is -5.67%. This represents a change of 30.19% compared to the average of -4.36% of the last 4 quarters.
iCAD, Inc. (ICAD) Historical ROE (quarterly & annually)
How has ICAD ROE performed in the past?
The mean historical ROE of iCAD, Inc. over the last ten years is -79.23%. The current -5.67% ROE has changed -92.84% with respect to the historical average. Over the past ten years (40 quarters), ICAD's ROE was at its highest in in the December 2023 quarter at 4.08%. The ROE was at its lowest in in the March 2019 quarter at -81.41%.
Average
-79.23%
Median
-49.01%
Minimum
-267.23%
Maximum
-14.50%
iCAD, Inc. (ICAD) ROE by Quarter and Year
Discovering the peaks and valleys of iCAD, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 6.07%
Maximum Annual ROE = -14.50%
Minimum Annual Increase = -78.41%
Minimum Annual ROE = -267.23%
| Year | ROE | Change |
|---|---|---|
| 2024 | -19.58% | 34.98% |
| 2023 | -14.50% | -62.93% |
| 2022 | -39.13% | 61.85% |
| 2021 | -24.17% | -58.10% |
| 2020 | -57.69% | -78.41% |
| 2019 | -267.23% | 104.37% |
| 2018 | -130.76% | 30.94% |
| 2017 | -99.86% | 147.58% |
| 2016 | -40.33% | -59.29% |
| 2015 | -99.09% | 6.07% |
iCAD, Inc. (ICAD) Average ROE
How has ICAD ROE performed in the past?
The current ROE of iCAD, Inc. (ICAD) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-24.40%
5-year avg
-31.01%
10-year avg
-79.23%
iCAD, Inc. (ICAD) ROE vs. Peers
How is ICAD’s ROE compared to its peers?
iCAD, Inc.’s ROE is greater than Asensus Surgical, Inc. (-117.89%), greater than Genetic Technologies Limited (-184.98%), greater than enVVeno Medical Corporation (-66.39%), greater than Neovasc Inc. (-121.07%), greater than Five Star Senior Living Inc. (-15.17%), greater than HilleVax, Inc. (-29.97%), greater than Cyteir Therapeutics, Inc. (-26.35%), less than Opiant Pharmaceuticals, Inc. (7.31%), greater than RVL Pharmaceuticals plc (-80.88%), greater than Augmedix, Inc. (-154.69%),
| Company | ROE | Market cap |
|---|---|---|
| -117.89% | $94.92M | |
| -184.98% | $111.24M | |
| -66.39% | $165.03K | |
| -121.07% | $82.86M | |
| -15.17% | $98.39M | |
| -29.97% | $104.76M | |
| -26.35% | $108.71M | |
| 7.31% | $108.80M | |
| -80.88% | $3.14M | |
| -154.69% | $115.91M |
Build a custom stock screener for iCAD, Inc. (ICAD) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like iCAD, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
iCAD, Inc. (ICAD) and other stocks custom spreadsheet templates
The easiest way to analyze a company like iCAD, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is iCAD, Inc.'s ROE?
How is the ROE calculated for iCAD, Inc. (ICAD)?
What is the highest ROE for iCAD, Inc. (ICAD)?
What is the 3-year average ROE for iCAD, Inc. (ICAD)?
What is the 5-year average ROE for iCAD, Inc. (ICAD)?
How does the current ROE for iCAD, Inc. (ICAD) compare to its historical average?